ZEB1 and glioblastoma: Given the dual nature of ZEB1 with respect to its ability to act as a transcriptional repressor or activator, one needs to determine if the coactivators or corepressors that are associated with ZEB1 are in fact functional in glioblastoma and are not subject to mutational events or other dysregulation that may affect ZEB1.